This inventor holds 1 USPTO granted patent. Top assignee: Uropep Biotech Gbr. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Michael Carsten Truss: Innovator in Prostatic Disease Treatment
Introduction
Michael Carsten Truss is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of medical science, particularly in the treatment of prostatic diseases. His innovative approach has led to the development of a patent that addresses critical health issues.
Latest Patents
Truss holds a patent for the "Use of phosphodiesterase inhibitors in the treatment of prostatic diseases." This invention pertains to the use of inhibitors of phosphodiesterase I, IV, and V for the prophylaxis and treatment of prostatic diseases. The patent highlights the potential benefits of these inhibitors in improving patient outcomes.
Career Highlights
Throughout his career, Michael Carsten Truss has been associated with Uropep Biotech GbR, a company focused on biotechnological advancements. His work has been instrumental in advancing therapeutic options for patients suffering from prostatic conditions.
Collaborations
Truss has collaborated with esteemed colleagues such as Wolf-Georg Forssmann and Christian Georg Stief. These partnerships have fostered a collaborative environment that enhances research and innovation in the field.
Conclusion
Michael Carsten Truss is a pioneering inventor whose work in the treatment of prostatic diseases has the potential to make a significant impact on healthcare. His contributions through patents and collaborations continue to advance medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile